Giuseppe Muscogiuri1,2, Wolfgang G Rehwald3,4, U Joseph Schoepf1, Pal Suranyi1, Sheldon E Litwin1,5, Carlo N De Cecco1, Julian L Wichmann1,6, Stefanie Mangold1,7, Damiano Caruso1,8, Stephen R Fuller1, Richard R Bayer Nd1,5, Akos Varga-Szemes1. 1. Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina, USA. 2. Department of Imaging, Bambino Gesu Children's Hospital IRCCS, Rome, Italy. 3. Siemens Medical Solutions, Chicago, Illinois, USA. 4. Cardiovascular MR Center, Duke University Medical Center, Durham, North Carolina, USA. 5. Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. 6. Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany. 7. Department of Diagnostic and Interventional Radiology, Eberhard-Karls University Tuebingen, Tuebingen, Germany. 8. Department of Radiological, Oncological and Pathological Sciences, University of Rome "Sapienza", Rome, Italy.
Abstract
PURPOSE: To evaluate a new dark-blood late gadolinium enhancement (LGE) technique called "T(Rho) And Magnetization transfer and INvErsion Recovery" (TRAMINER) for the ability to detect myocardial LGE versus standard "bright-blood" inversion recovery (SIR) imaging. MATERIALS AND METHODS: This Institutional Review Board (IRB)-approved, Health Insurance Portability and Accountability Act (HIPAA)-compliant prospective study included 40 patients (62 ± 14 years [mean ± standard deviation (SD)], 29 males) with suspected myocardial infarction (MI) referred for the assessment of myocardial viability. The patients underwent a 1.5T cardiac magnetic resonance imaging (MRI) including postcontrast SIR and TRAMINER acquisitions. Normalized images were evaluated by two readers. Subjective (3-point Likert scale) and objective image qualities were compared using Mann-Whitney U-test and paired t-test, respectively. Interobserver agreement, LGE detection rate, and level of certainty were compared using Cohen's kappa, Wilcoxon-test, and Mann-Whitney U-test, respectively. Results are reported as mean ± SD or mean [95% confidence interval]. RESULTS: Overall, image quality was rated similar between TRAMINER and SIR; however, TRAMINER performed better on a visual assessment of the ability to differentiate LGE from blood (Likert scale: 3.0 [3.0-3.0] vs. 2.0 [1.7-2.2], P < 0.0001). TRAMINER provided significantly higher signal intensity range (69.8 ± 10.2 vs. 9.6 ± 7.6, P < 0.0001) and a 4-fold higher signal intensity ratio (4.2 ± 1.9 vs. 1.1 ± 0.1, P < 0.0001) between LGE and blood signals. TRAMINER detected more patients (19/40 vs. 17/40) and segments (91/649 vs. 79/649) with LGE with higher level of certainty (2.9 [2.8-3.0] vs. 2.7 [2.5-2.8], P = 0.0185). Interobserver agreement was good to excellent for LGE detection. CONCLUSION: TRAMINER provides better contrast between LGE and blood and consequently may have increased ability to discriminate thin subendocardial and papillary muscle enhancement from the blood signal, which can have an indistinct appearance using SIR. LEVEL OF EVIDENCE: 2 J. MAGN. RESON. IMAGING 2017;45:1429-1437.
PURPOSE: To evaluate a new dark-blood late gadolinium enhancement (LGE) technique called "T(Rho) And Magnetization transfer and INvErsion Recovery" (TRAMINER) for the ability to detect myocardial LGE versus standard "bright-blood" inversion recovery (SIR) imaging. MATERIALS AND METHODS: This Institutional Review Board (IRB)-approved, Health Insurance Portability and Accountability Act (HIPAA)-compliant prospective study included 40 patients (62 ± 14 years [mean ± standard deviation (SD)], 29 males) with suspected myocardial infarction (MI) referred for the assessment of myocardial viability. The patients underwent a 1.5T cardiac magnetic resonance imaging (MRI) including postcontrast SIR and TRAMINER acquisitions. Normalized images were evaluated by two readers. Subjective (3-point Likert scale) and objective image qualities were compared using Mann-Whitney U-test and paired t-test, respectively. Interobserver agreement, LGE detection rate, and level of certainty were compared using Cohen's kappa, Wilcoxon-test, and Mann-Whitney U-test, respectively. Results are reported as mean ± SD or mean [95% confidence interval]. RESULTS: Overall, image quality was rated similar between TRAMINER and SIR; however, TRAMINER performed better on a visual assessment of the ability to differentiate LGE from blood (Likert scale: 3.0 [3.0-3.0] vs. 2.0 [1.7-2.2], P < 0.0001). TRAMINER provided significantly higher signal intensity range (69.8 ± 10.2 vs. 9.6 ± 7.6, P < 0.0001) and a 4-fold higher signal intensity ratio (4.2 ± 1.9 vs. 1.1 ± 0.1, P < 0.0001) between LGE and blood signals. TRAMINER detected more patients (19/40 vs. 17/40) and segments (91/649 vs. 79/649) with LGE with higher level of certainty (2.9 [2.8-3.0] vs. 2.7 [2.5-2.8], P = 0.0185). Interobserver agreement was good to excellent for LGE detection. CONCLUSION: TRAMINER provides better contrast between LGE and blood and consequently may have increased ability to discriminate thin subendocardial and papillary muscle enhancement from the blood signal, which can have an indistinct appearance using SIR. LEVEL OF EVIDENCE: 2 J. MAGN. RESON. IMAGING 2017;45:1429-1437.
Authors: Sebastian Gassenmaier; Rob J van der Geest; U Joseph Schoepf; Pal Suranyi; Wolfgang G Rehwald; Carlo N De Cecco; Domenico Mastrodicasa; Moritz H Albrecht; Domenico De Santis; Virginia W Lesslie; Balazs Ruzsics; Akos Varga-Szemes Journal: Int J Cardiovasc Imaging Date: 2018-01-05 Impact factor: 2.357
Authors: Ya-Jun Ma; Shujuan Fan; Hongda Shao; Jiang Du; Nikolaus M Szeverenyi; Ian R Young; Graeme M Bydder Journal: Quant Imaging Med Surg Date: 2020-06
Authors: Han W Kim; Wolfgang G Rehwald; Elizabeth R Jenista; David C Wendell; Peter Filev; Lowie van Assche; Christoph J Jensen; Michele A Parker; Enn-Ling Chen; Anna Lisa C Crowley; Igor Klem; Robert M Judd; Raymond J Kim Journal: JACC Cardiovasc Imaging Date: 2017-12-13
Authors: Linsheng Song; Xiaohai Ma; Xinxiang Zhao; Lei Zhao; Mark DeLano; Yang Fan; Bin Wu; Aijia Lu; Jie Tian; Liping He Journal: Cardiovasc Diagn Ther Date: 2020-04
Authors: Robert J Holtackers; Caroline M Van De Heyning; Amedeo Chiribiri; Joachim E Wildberger; René M Botnar; M Eline Kooi Journal: J Cardiovasc Magn Reson Date: 2021-07-22 Impact factor: 5.364
Authors: Peter Kellman; Hui Xue; Laura J Olivieri; Russell R Cross; Elena K Grant; Marianna Fontana; Martin Ugander; James C Moon; Michael S Hansen Journal: J Cardiovasc Magn Reson Date: 2016-11-07 Impact factor: 5.364
Authors: Robert J Holtackers; Amedeo Chiribiri; Torben Schneider; David M Higgins; René M Botnar Journal: J Cardiovasc Magn Reson Date: 2017-08-23 Impact factor: 5.364